Integrated Advisors Network LLC Eli Lilly & CO Transaction History

Integrated Advisors Network LLC

$2.08 Billion
Q3 2024

A detailed history of Integrated Advisors Network LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Integrated Advisors Network LLC holds 11,582 shares of LLY stock, worth $8.89 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

11,582

Previous 11,260 2.86%

Holding current value

$8.89 Million

Previous $10.2 Million 0.65%

% of portfolio

0.49%

Previous 0.53%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$772.14 - $960.02 $248,629 - $309,126	322 Added 2.86%	11,582 $10.3 Million
Q2 2024 Aug 09, 2024	SELL	$724.87 - $909.04 $94,233 - $118,175	-130 Reduced 1.14%	11,260 $10.2 Million
Q1 2024 May 03, 2024	SELL	$592.2 - $792.28 $230,958 - $308,989	-390 Reduced 3.31%	11,390 $8.86 Million
Q4 2023 Feb 26, 2024	BUY	$525.19 - $619.13 $141,801 - $167,165	270 Added 2.35%	11,780 $6.87 Million
Q3 2023 Nov 16, 2023	SELL	$434.7 - $599.3 $123,889 - $170,800	-285 Reduced 2.42%	11,510 $6.18 Million
Q2 2023 Jul 14, 2023	BUY	$350.74 - $468.98 $21,745 - $29,076	62 Added 0.53%	11,795 $5.53 Million
Q1 2023 May 05, 2023	BUY	$310.63 - $364.82 $396,985 - $466,239	1,278 Added 12.22%	11,733 $4.03 Million
Q4 2022 Feb 02, 2023	BUY	$321.55 - $374.67 $3.36 Million - $3.92 Million	10,455 New	10,455 $3.82 Million
Q3 2022 Nov 07, 2022	BUY	$296.48 - $337.87 $230,068 - $262,187	776 Added 10.77%	7,981 $2.58 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $171,140 - $200,943	614 Added 9.32%	7,205 $2.34 Million
Q1 2022 May 02, 2022	SELL	$234.69 - $291.66 $2.39 Million - $2.97 Million	-10,195 Reduced 60.74%	6,591 $1.89 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $84,318 - $104,640	375 Added 2.29%	16,786 $4.64 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $113,902 - $140,172	-514 Reduced 3.04%	16,411 $3.79 Million
Q2 2021 Aug 06, 2021	SELL	$180.55 - $233.54 $434,403 - $561,897	-2,406 Reduced 12.45%	16,925 $3.89 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $315,823 - $408,847	1,922 Added 11.04%	19,331 $3.61 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $2,087 - $2,762	-16 Reduced 0.09%	17,409 $2.94 Million
Q3 2020 Nov 09, 2020	SELL	$146.22 - $169.13 $486,035 - $562,188	-3,324 Reduced 16.02%	17,425 $2.58 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $52,794 - $63,537	-387 Reduced 1.83%	20,749 $3.41 Million
Q1 2020 May 06, 2020	SELL	$119.05 - $147.35 $24,524 - $30,354	-206 Reduced 0.97%	21,136 $2.93 Million
Q4 2019 Feb 06, 2020	BUY	$106.92 - $132.43 $2.28 Million - $2.83 Million	21,342 New	21,342 $2.81 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Advisors Network LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Advisors Network LLC with notifications on news.

Account

Integrated Advisors Network LLC Eli Lilly & CO Transaction History